Focus Partners Wealth
KURA icon

Focus Partners Wealth’s Kura Oncology KURA Stock Holding History

Focus Partners Wealth’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
28,418
+11,609
+69% +$110K ﹤0.01% 2242
2026
Q1 		$137K Sell
16,809
-7,850
-32% -$67.4K ﹤0.01% 2475
2025
Q4 		$256K Buy
24,659
+8,458
+52% +$88.7K ﹤0.01% 2312
2025
Q3 		$143K Buy
+16,201
New +$115K ﹤0.01% 2096

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Focus Partners Wealth's KURA Position: Q2 2026 in Review

Focus Partners Wealth increased its Kura Oncology (KURA) stake by 69% in Q2 2026, buying an estimated $110K and bringing the position to 28,418 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Focus Partners Wealth first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Focus Partners Wealth held 28,418 shares of Kura Oncology worth $312K as of Q2 2026.
  • Focus Partners Wealth bought 11,609 Kura Oncology shares in Q2 2026, an estimated $110K.
  • Kura Oncology made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2242 holding.
  • Focus Partners Wealth first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.